Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

When facing a diagnosis or suspicious tumor related to urologic cancers, such as prostate, kidney, or bladder cancer, it can ...

A new generation of therapeutics looks beyond simply reengineering the gut microbiome to exploiting multiple pathways for novel microbiome and microbial applications.

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for Anktiva ...

Reports Q4 revenue $7.55M, consensus $9.51M. “The first quarter of 2025 has been an inflection point for the Company with multiple milestones ...

Join the University of Exeter's £6.5m project to help the NHS achieve net-zero carbon emissions by 2045, developing tools to ...

Handelsbanken Fonder AB purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 13,300 shares of the ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...

Development of a new business park continues; the Erie Times-News previously reported that tons of dangerous materials were abandoned at the property.

DelveInsight’s, “Gastric Cancer Pipeline Insight” report provides comprehensive insights about 200+ companies and 220+ ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open. It surged on news its high-protein lupin isolate was approved for export into China.

It took nearly three years to win presumptive workers' compensation coverage for breast, cervical, and other cancers that ...